Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 450

1.

Mechanisms underlying the pathogenesis of hyper-contractility of bronchial smooth muscle in allergic asthma.

Sakai H, Suto W, Kai Y, Chiba Y.

J Smooth Muscle Res. 2017;53(0):37-47. doi: 10.1540/jsmr.53.37.

2.

The importance of being ncRNAs: from bit players as "junk DNA" to rising stars on the stage of the pharmaceutical industry.

Di Mauro V, Catalucci D.

Ann Transl Med. 2017 Mar;5(6):147. doi: 10.21037/atm.2017.01.20. No abstract available.

3.

Role of MicroRNA in cardiac anesthesia: An innovative consequences and new possibility.

Barik M, Kumar A, Mishra PR, Kapoor PM.

Ann Card Anaesth. 2017 Apr-Jun;20(2):274-275. doi: 10.4103/aca.ACA_37_16. No abstract available.

4.

The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application.

Sun T, Dong YH, Du W, Shi CY, Wang K, Tariq MA, Wang JX, Li PF.

Int J Mol Sci. 2017 Mar 31;18(4). pii: E745. doi: 10.3390/ijms18040745. Review.

5.

Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.

Liu X, Liu S.

Biomed Rep. 2017 Feb;6(2):140-145. doi: 10.3892/br.2017.841. Epub 2017 Jan 12.

6.

A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.

Naga Prasad SV, Gupta MK, Duan ZH, Surampudi VS, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Karnik S.

PLoS One. 2017 Mar 22;12(3):e0170456. doi: 10.1371/journal.pone.0170456. eCollection 2017.

7.

The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.

Gao J, Xu W, Wang J, Wang K, Li P.

Int J Mol Sci. 2017 Mar 10;18(3). pii: E608. doi: 10.3390/ijms18030608. Review.

8.

Bioinformatics Analysis Reveals MicroRNAs Regulating Biological Pathways in Exercise-Induced Cardiac Physiological Hypertrophy.

Xu J, Liu Y, Xie Y, Zhao C, Wang H.

Biomed Res Int. 2017;2017:2850659. doi: 10.1155/2017/2850659. Epub 2017 Feb 14. Review.

9.

Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes.

de Gonzalo-Calvo D, van der Meer RW, Rijzewijk LJ, Smit JW, Revuelta-Lopez E, Nasarre L, Escola-Gil JC, Lamb HJ, Llorente-Cortes V.

Sci Rep. 2017 Dec;7(1):47. doi: 10.1038/s41598-017-00070-6. Epub 2017 Mar 3.

10.

Micro-RNAs as promising biomarkers in cardiac diseases.

Akodad M, Mericskay M, Roubille F.

Ann Transl Med. 2016 Dec;4(24):551. doi: 10.21037/atm.2016.12.38. No abstract available.

11.

Role of microRNAs in cardiac development and disease.

Tian J, An X, Niu L.

Exp Ther Med. 2017 Jan;13(1):3-8. doi: 10.3892/etm.2016.3932. Epub 2016 Nov 28.

12.

Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Jung JH, Fu X, Yang PC.

Circ Res. 2017 Jan 20;120(2):407-417. doi: 10.1161/CIRCRESAHA.116.309307. Review.

PMID:
28104773
13.

Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo.

Li P, Yin YL, Guo T, Sun XY, Ma H, Zhu ML, Zhao FR, Xu P, Chen Y, Wan GR, Jiang F, Peng QS, Liu C, Liu LY, Wang SX.

Circulation. 2016 Nov 29;134(22):1752-1765. Epub 2016 Oct 20.

14.

Role of oxidized lipids in pulmonary arterial hypertension.

Sharma S, Ruffenach G, Umar S, Motayagheni N, Reddy ST, Eghbali M.

Pulm Circ. 2016 Sep;6(3):261-73. doi: 10.1086/687293. Review.

15.

Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

Dhingra R, Vasan RS.

Trends Cardiovasc Med. 2017 Feb;27(2):123-133. doi: 10.1016/j.tcm.2016.07.005. Epub 2016 Jul 28. Review.

PMID:
27576060
16.

Tanshinone IIA protects H9c2 cells from oxidative stress-induced cell death via microRNA-133 upregulation and Akt activation.

Gu Y, Liang Z, Wang H, Jin J, Zhang S, Xue S, Chen J, He H, Duan K, Wang J, Chang X, Qiu C.

Exp Ther Med. 2016 Aug;12(2):1147-1152. Epub 2016 May 26.

17.

Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.

Spengler RM, Zhang X, Cheng C, McLendon JM, Skeie JM, Johnson FL, Davidson BL, Boudreau RL.

Nucleic Acids Res. 2016 Sep 6;44(15):7120-31. doi: 10.1093/nar/gkw640. Epub 2016 Jul 14.

18.

Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase.

Nandi SS, Zheng H, Sharma NM, Shahshahan HR, Patel KP, Mishra PK.

Diabetes. 2016 Oct;65(10):3075-90. doi: 10.2337/db16-0023. Epub 2016 Jul 13.

19.

Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.

Navickas R, Gal D, Laucevičius A, Taparauskaitė A, Zdanytė M, Holvoet P.

Cardiovasc Res. 2016 Sep;111(4):322-37. doi: 10.1093/cvr/cvw174. Epub 2016 Jun 29. Review.

20.

A microRNA isolation method from clinical samples.

Zununi Vahed S, Barzegari A, Rahbar Saadat Y, Mohammadi S, Samadi N.

Bioimpacts. 2016;6(1):25-31. doi: 10.15171/bi.2016.04. Epub 2016 Mar 28.

Supplemental Content

Support Center